Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President-Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Biren Amin | Jefferies |
Marc Frahm | Cowen & Company |
Tyler Van Buren | Piper Sandler |
Michael Schmidt | Guggenheim |
John Newman | Canaccord |
Mark Breidenbach | Oppenheimer |
Lisa Walter | RBC |
Ren Benjamin | JMP Securities |
Carolina Ibanez | Stifel |
Sadia Rahman | Bank of America |
Raju Prasad | William Blair |
Asthika Goonewardene | Truist Securities |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Allogene Therapeutics Fourth Quarter and Year-end 2020 Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded.